Stem Cell Cryopreservation Market Report 2026

Stem Cell Cryopreservation Market Overview

• Stem Cell Cryopreservation market size has reached to $4.17 billion in 2025 • Expected to grow to $10.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.5% • Growth Driver: The Increasing Prevalence Of Degenerative Diseases Drives The Growth Of The Market Due To Rising Demand For Regenerative Therapies • Market Trend: Innovative Freezing Solutions Enhance Cell Viability And Enable Scalable Therapy Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stem Cell Cryopreservation Market?

Stem cell cryopreservation refers to the process of preserving stem cells at ultra-low temperatures to maintain their viability and biological functions for long-term use. This technique allows stem cells to be stored safely for future therapeutic applications, research, or transplantation. The main types of stem cell cryopreservation are embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Embryonic stem cells are pluripotent cells derived from the inner cell mass of a blastocyst, capable of differentiating into any cell type of the body. They are used in various applications, including cell freezing media, equipment, and consumables, and cater to various end-users, such as biopharmaceutical companies, research institutes, blood banks, and in vitro fertilization (IVF) clinics.

What Is The Stem Cell Cryopreservation Market Growth Forecast?

The stem cell cryopreservation market size is expected to see rapid growth in the next few years. It will grow to $10.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine therapies, growing investments in biobanking infrastructure, rising demand for personalized medicine storage solutions, expansion of clinical cell therapy pipelines, increasing focus on standardized storage protocols. Major trends in the forecast period include increasing demand for long-term stem cell storage, rising use of advanced cryoprotectants, growing adoption of automated cryopreservation systems, expansion of stem cell banking services, enhanced focus on cell viability preservation.

Global Stem Cell Cryopreservation Market Segmentation

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell 2) By Application: Cell Freezing Media, Equipment And Consumables 3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics Subsegments: 1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells 2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell 3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

What Is The Driver Of The Stem Cell Cryopreservation Market?

The increasing prevalence of degenerative diseases is expected to propel the growth of the stem cell cryopreservation market going forward. Degenerative diseases refer to medical conditions in which the structure or function of tissues or organs progressively deteriorates over time, often leading to loss of normal function. The increasing prevalence of degenerative diseases is due to the growing aging population, as older individuals are more susceptible to cellular and tissue deterioration that leads to such conditions. Stem cell cryopreservation enables the long-term storage of viable stem cells, providing a reliable source for regenerative therapies that help repair and replace damaged tissues in degenerative diseases. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060. Therefore, the increasing prevalence of degenerative diseases is driving the growth of the stem cell cryopreservation industry.

Key Players In The Global Stem Cell Cryopreservation Market

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Global Stem Cell Cryopreservation Market Trends and Insights

Major companies operating in the stem cell cryopreservation market are focusing on developing innovative solutions such as advanced cryopreservation media and automation-friendly freezing systems to enhance post-thaw cell viability and accelerate stem cell therapy development. Advanced cryopreservation media are specially formulated solutions that protect stem cells during freezing and thawing to maintain their viability and function, while automation-friendly freezing systems are equipment or processes designed for scalable, reproducible, and hands-free freezing of cells in large-scale manufacturing. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, a proprietary cryopreservation medium. This advanced solution is engineered to enhance the freezing and thawing of pluripotent stem cells and other sensitive cell types, ensuring higher post-thaw viability and functional integrity. These media featuring an entirely synthetic, animal-origin-free formulation with low viscosity, PluriFreeze is ideal for automated and large-scale cell production. It is complemented by the DMSO-free PluriPrep wash solution, allowing extended processing times. Made from Generally Recognized as Safe (GRAS) components, the medium delivers consistent, reliable, and safe cryopreservation for both research and clinical applications. By integrating seamlessly with platforms such as PluriBank, this launch strengthens the stem cell cryopreservation workflow, providing efficient and scalable solutions from laboratory research to clinical implementation.

What Are Latest Mergers And Acquisitions In The Stem Cell Cryopreservation Market?

In April 2025, BioLife Solutions Inc., a US-based healthcare technology company, acquired a 90% stake in PanTHERA CryoSolutions Inc. for $21.53 million. With this acquisition, BioLife Solutions aims to strengthen its technological capabilities in stem cell cryopreservation and expand its presence in advanced biobanking solutions. PanTHERA CryoSolutions Inc. is a Canada-based healthcare technology company that specializes in providing innovative cryopreservation services and solutions for stem cells and other cellular therapies.

Regional Outlook

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell Cryopreservation Market?

The stem cell cryopreservation market consists of revenues earned by entities by providing services such as collection and processing of stem cells, long-term storage and preservation, quality testing and viability assessment, regulatory compliance and documentation services, and insurance and risk management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem cell cryopreservation market also includes sales of ultra-low-temperature storage equipment, rewarming devices, storage and retrieval systems, and ancillary support products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stem Cell Cryopreservation Market Report 2026?

The stem cell cryopreservation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell cryopreservation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.